COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,893 Articles (22,568 medRxiv, 8,325 bioRxiv)

Most recent first Previous |  Page 210: Articles 2091-2100  | Next

Immune history influences SARS-CoV-2 booster impacts: the role of efficacy and redundancy
Larsen, S. L., Noor, I., West, H., Chandra, E., Martinez, P. P., Kraay, A. N. M.
10.1101/2024.03.06.24303879 — Posted: 2024-03-08
SARS-CoV-2 antibody prevalence by industry, workplace characteristics, and workplace infection prevention and control measures, North Carolina, 2021 to 2022
Gigot, C., Pisanic, N., Spicer, K., Davis, M. F., Kruczynski, K., Gregory Rivera, M., Koehler, K., Hall, D. J., Hall, D. J., Heaney, C. D.
10.1101/2024.03.06.24303821 — Posted: 2024-03-08
Follow-up after post-exposure prophylaxis before and during the COVID-19 pandemic in Brazil
MATSUDA, E. M., CAMPOS, I. B., BRIGIDO, L. F. D. M.
10.1101/2024.03.07.24303803 — Posted: 2024-03-08
Physical and sociocultural factors influencing hand hygiene behaviour during COVID-19 pandemic: A cross-sectional study among traders in Lusaka District, Zambia
Siame, J. N., Libonda, L., Kanyata, K.
10.1101/2024.03.06.24303900 — Posted: 2024-03-08
Suicidal behavior during the Covid-19 pandemic: Results from cross-sectional surveys of Brazilian adults from 2020 to 2022
Faro, A., Palhano, D., Silva, L., Falk, D.
10.1101/2024.03.06.24303895 — Posted: 2024-03-08
Power spectra density and similarity analysis of COVID-19 mortality waves across countries
Manjarrez, E., Delfin, E. F., Dominguez-Nicolas, S. M., Flores, A.
10.1101/2024.03.06.24303885 — Posted: 2024-03-08
How to mitigate selection bias in COVID-19 surveys: evidence from five national cohorts
Narayanan, M. K., Dodgeon, B., Katsoulis, M., Ploubidis, G. B., Silverwood, R. J.
10.1101/2024.03.06.24303781 — Posted: 2024-03-08
Tracking Persistent Symptoms in Scotland (TraPSS): A Longitudinal Prospective Cohort Study of COVID-19 Recovery After Mild Acute Infection
Sculthorpe, N., Mclaughlin, M., Cerexhe, L., Macdonald, E., Dello Iacono, A., Sanal-Hayes, N., Ingram, J., Meach, R., Carless, D., Ormerod, J., Hayes, L. D. D.
10.1101/2024.03.07.24303931 — Posted: 2024-03-08
In silico genomic surveillance by CoVerage predicts and characterizes SARS-CoV-2 Variants of Interest
Norwood, K., Deng, Z.-L., Reimering, S., Robertson, G., Foroughmand-Araabi, M.-H., Goliaei, S., Hoelzer, M., McHardy, A. C.
10.1101/2024.03.07.583829 — Posted: 2024-03-08
Rapid Degradation of the Human ACE2 Receptor Upon Binding and Internalization of SARS-Cov-2-Spike-RBD Protein
Feinstein, P.
10.1101/2024.03.07.583884 — Posted: 2024-03-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).